Parkinsonism and distinct dementia patterns in a family with the MAPT R406W mutation

Alzheimer's and Dementia

Volumn 10, Issue 3, 2014, Pages 360-365

  Carney, Regina M ^a   Kohli, Martin A ^a   Kunkle, Brian W ^a   Naj, Adam C ^a   Gilbert, John R ^a   Züchner, Stephan ^a   Pericak Vance, Margaret A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Dementia; Early onset Alzheimer's disease; Frontotemporal dementia; Microtubule associated protein tau; Whole exome sequencing

Indexed keywords

TAU PROTEIN; MAPT PROTEIN, HUMAN;

ALZHEIMER DISEASE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL EVALUATION; CLINICAL FEATURE; CORRELATION ANALYSIS; DEMENTIA; DISEASE ASSOCIATION; EARLY ONSET ALZHEIMER DISEASE; EXOME; FAMILY; FRONTOTEMPORAL DEMENTIA; GENE; GENE SEQUENCE; HUMAN; MAPT GENE; MISSENSE MUTATION; ONSET AGE; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; CASE REPORT; DISEASE COURSE; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PEDIGREE; PROCEDURES;

DEMENTIA; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FAMILY; HUMANS; MIDDLE AGED; MUTATION, MISSENSE; PARKINSONIAN DISORDERS; PEDIGREE; TAU PROTEINS;

EID: 84899636409     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2013.02.011     Document Type: Article

References (40)

1. Miyoshi K. What is "early onset dementia?". Psychogeriatrics 2009; 9:67-72.
2. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-105.
3. Goate A, Chartier-Harlin M, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349:704-6.
4. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levasque G, Ikeda M, et al. Cloning of a gene bearing mis-sense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-60.
5. Rogaev EI, Sherrington R, Rogeava EA, Levesque G, Ikeda M, Liang Y, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995;376:775-8.
6. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 1998; 539:1914-7.
7. Reed LA, Grabowski TJ, Schmidt ML, Morris JC, Goate A, Solodkin A, et al. Autosomal dominant dementia with widespread neurofibrillary tangles. Ann Neurol 1997;4:564-72.
8. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-5.
9. Rosso SM, Donker Kaat L, Baks T, Joosse M, de Koning I, Pijnenburg Y, et al. Frontotemporal dementia in the Netherlands: patient characteristics and prevalence estimates from a populationbased study. Brain 2003;9:2016-22.
10. Passant U, Ostojic J, Froelich Fabre S, Gustafson L, Lannfelt L, Larsson EM, et al. Familial presenile dementia with bitemporal atrophy. Dement Geriatr Cogn Disord 2004;4:287-92.
11. Ostojic J, Elfgren C, Passant U, Nilsson K, Gustafson L, Lannfelt L, et al. The tau R406W mutation causes progressive presenile dementia with bitemporal atrophy. Dement Geriatr Cogn Disord 2004; 4:298-301.
12. van Swieten JC, Stevens M, Rosso SM, Rizzu P, Joosse M, de Koning I, et al. Phenotypic variation in hereditary frontotemporal dementia with tau mutations. Ann Neurol 1999;4:617-26.
13. Rademakers R, Dermaut B, Peeters K, Cruts M, Heutink P, Goate A, et al. Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in western Europe. Hum Mutat 2003;5:409-11.
14. Lindquist SG, Holm IE, Schwartz M, Law I, Stokholm J, Batbayli M, et al. Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation. Eur J Neurol 2008; 15:377-85.
15. Lindquist SG, Schwartz M, Batbayli M,Waldemar G, Nielsen JE. Genetic testing in familial AD and FTD: mutation and phenotype spectrum in a Danish cohort. Clin Genet 2009;2:205-9.
16. Ikeuchi T, Kaneko H, Miyashita A, Nozaki H, Kasuga K, Tsukie T, et al. Mutational analysis in early-onset familial dementia in the Japanese population: the role of PSEN1 and MAPT R406W mutations. Dement Geriatr Cogn Disord 2008;1:43-9.
17. Saito Y, Geyer A, Sasaki R, Kuzuhara S, Nanba E, Miyasaka T, et al. Early-onset, rapidly progressive familial tauopathy with R406W mutation. Neurology 2002;5:811-3.
18. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010;9:1297-303.
19. Cruts M, Theuns J, Van Broeckhoven C. Locus-specific mutation databases for neurodegenerative brain diseases. Hum Mutat 2012; 33:1340-4.
20. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
21. Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999;8:711-5.
22. Cruts M, Rademakers R, Gijselinck I, van der Zee J, Dermaut B, de Pooter T, et al. Genomic architecture of human 17q21 linked to frontotemporal dementia uncovers a highly homologous family of lowcopy repeats in the tau region. Hum Mol Genet 2005;14:1753-62.
23. Kohli MA, John-Williams K, Rajbhandary R, Naj A, Whitehead P, Hamilton K, et al. Repeat expansions in the C9ORF72 gene contribute to Alzheimer's disease in Caucasians. Neurobiol Aging 2013;34. 1519.e5-e12.
24. Dejesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011;72:245-56.
25. Naj AC, Jun G, BeechamGW,Wang LS, Vardarajan BN, Buros J, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature Genet 2011;43:436-41.
26. Zabetian CP, Hutter CM, Factor SA, Nutt JG, Higgins DS, Griffith A, et al. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Ann Neurol 2007;62:137-44.
27. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al. a-Synuclein locus triplication causes Parkinson's disease. Science 2003;302:841.
28. Dachsel JC, Farrer MJ. LRRK2 and Parkinson disease. Arch Neurol 2010;67:542-7.
29. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392:605-8.
30. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003;299:256-9.
31. Valente EM, Salvi S, Ialongo T, Marongiu R, Elia AE, Caputo V, et al. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol 1998;56:336-41.
32. Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 2007;39:168-77.
33. McKhann G, Drachman D, Folstein M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
34. Folstein MF, Folstein SE, McHugh PR. Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;3:189-98.
35. Ludolph AC, Kassubek J, Landwehrmeyer BG, Mandelkow E, Mandelkow E-M, Burn DJ, et al. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol 2009;16:297-309.
36. Foster NL, Wilhelmsen K, Sima AA, Jones MZ, D'Amato CJ, Gilman S. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann Neurol 1997; 41:706-15.
37. Taipa R, Pinho J, Melo-Pires M. Clinico-pathological correlations of the most common neurodegenerative dementias. Front Neurol 2012; 3:1-13.
38. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47:1-9.
39. Belfor N, Amici S, Boxer AL, Kramer JH, Gorno-Tempini ML, Rosen HJ, et al. Clinical and neuropsychological features of corticobasal degeneration. Mech Ageing Dev 2006;127:203-7.
40. Snowden JS, Thompson JC, Stopford CL, Richardson AM, Gerhard A, Neary D, et al. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships. Brain 2011; 134:2478-92.